Fairmount Funds Management LLC Insider Profile
67 Followers
Fairmount Funds Management LLC, Director, Ten Percent Owner at Korsana Biosciences, holds ― shares in Korsana Biosciences (Ticker: KRSA), holds 0.00 shares in Apogee Therapeutics (Ticker: APGE), holds 3.60M shares in Crescent Biopharma (Ticker: CBIO). Most recently, Fairmount Funds Management LLC ― shares of Korsana Biosciences on ― for an estimated value of ―.
Fairmount Funds Management LLC Korsana Biosciences (KRSA)Director, Ten Percent Owner
Korsana Biosciences (KRSA)
Director, Ten Percent Owner
Ranked #977 out of 109,030 Corporate Insiders
Profitable Transactions
18 out of 24 Profitable Transactions
Average Return
+41.00%
Average return per transaction
Time Frame
Compare to
Insider Holdings
A breakdown of Fairmount Funds Management LLC's holdings
Insider Roles
Roles that Fairmount Funds Management LLC holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Jul 14, 2025 - Jul 14, 2026
Return:+256.40%
The most profitable trade made by Fairmount Funds Management LLC
Fairmount Funds Management LLC's Trading History
Korsana Biosciences
―
Director, Ten Percent Owner
―
―
Cogent Biosciences
Mar 31, 2026
Director
Informative Sell
242.62M
$180.18M
Viridian Therapeutics
May 13, 2026
Director, Ten Percent Owner
Informative Buy
20.00M
$111.13M
Apogee Therapeutics
Sep 03, 2026
―
Uninformative Sell
―
$0.00
Dianthus Therapeutics
Oct 01, 2024
Director
Uninformative Sell
―
$282.95M
Spyre Therapeutics
Jun 23, 2026
Director
Informative Sell
399.66M
$73.86M
Oruka Therapeutics
Jul 01, 2026
Director, Ten Percent Owner
Informative Sell
300.01M
$341.63M
Zenas BioPharma, Inc.
Apr 01, 2026
Director
Informative Buy
3.00M
$75.32M
Jade Biosciences
Oct 08, 2025
Director, Ten Percent Owner
Uninformative Buy
12.18M
$79.14M
Crescent Biopharma
Jul 20, 2026
Director, Ten Percent Owner
Informative Buy
12.38M
$67.70M
Damora Therapeutics
Feb 12, 2026
Director, Ten Percent Owner
Uninformative Buy
209.11M
$215.65M
List of latest transactions for each holding click on a transaction to see Fairmount Funds Management LLC's performance on stock
You May Also Like
Fairmount Funds Management LLC insider profile FAQ
What is the percentage of profitable transactions made by Fairmount Funds Management LLC?
The percentage of profitable transactions made by Fairmount Funds Management LLC is 75%.
What is the average return per transaction made by Fairmount Funds Management LLC?
The average return per transaction made by Fairmount Funds Management LLC is 41.00%.
What stocks does Fairmount Funds Management LLC hold?
Fairmount Funds Management LLC holds: KRSA, COGT, VRDN, APGE, DNTH, SYRE, ORKA, ZBIO, JBIO, CBIO, DMRA stocks.
What was Fairmount Funds Management LLC’s latest transaction?
Fairmount Funds Management LLC latest transaction was an Uninformative Buy of ―.
What was Fairmount Funds Management LLC's most profitable transaction?
Fairmount Funds Management LLC’s most profitable transaction was an Informative Buy of COGT stock on July 14, 2025. The return on the trade was 256.40%.
What is Fairmount Funds Management LLC's role in Korsana Biosciences?
Fairmount Funds Management LLC's role in Korsana Biosciences is Director, Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.